NovaBay Pharmaceuticals, Inc. (formerly known as NovaCal Pharmaceuticals, Inc.) Featured In November/December Issue of PharmaVOICE

EMERYVILLE, Calif.--(BUSINESS WIRE)--Two NovaBay Pharmaceuticals, Inc. (AMEX & TSX: NBY)(http://www.novabaypharma.com) executives, Chairman and CEO Ron Najafi, Ph.D., and VP of Research, Nafsika Georgopapadakou, Ph.D., shared their expert opinions in PharmaVOICE’s “Crystal Ball” feature in the magazine’s November/December issue.